105 related articles for article (PubMed ID: 34706519)
1. A five-year follow up study of stage I-IV of rectal cancer with an emphasis on epidermal growth factor over-expression.
Kozłowska-Geller MA; Lewitowicz P; Głuszek SZ
Pol J Pathol; 2021; 72(2):124-129. PubMed ID: 34706519
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up study of stage I-IV rectal cancer including EGFR immunoexpression and p21 immunoactivity.
Kozłowska-Geller M; Głuszek S; Lewitowicz P
Prz Gastroenterol; 2021; 16(4):330-338. PubMed ID: 34976241
[TBL] [Abstract][Full Text] [Related]
3. The expression of epidermal growth factor receptor results in a worse prognosis for patients with rectal cancer treated with preoperative radiotherapy: a multicenter, retrospective analysis.
Giralt J; de las Heras M; Cerezo L; Eraso A; Hermosilla E; Velez D; Lujan J; Espin E; Rosello J; Majó J; Benavente S; Armengol M; de Torres I;
Radiother Oncol; 2005 Feb; 74(2):101-8. PubMed ID: 15816107
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor is a predictor of tumor response in locally advanced rectal cancer patients treated with preoperative radiotherapy.
Giralt J; Eraso A; Armengol M; Rosselló J; Majó J; Ares C; Espin E; Benavente S; de Torres I
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1460-5. PubMed ID: 12459370
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of changes of tumor epidermal growth factor receptor expression after neoadjuvant chemoradiation in patients with rectal adenocarcinoma.
Dvorak J; Sitorova V; Ryska A; Sirak I; Richter I; Hatlova J; Ferko A; Melichar B; Petera J
Strahlenther Onkol; 2012 Sep; 188(9):833-8. PubMed ID: 22847519
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of hepatocyte growth factor and epiregulin are associated with the prognosis on anti-EGFR antibody treatment in KRAS wild-type metastatic colorectal cancer.
Takahashi N; Yamada Y; Furuta K; Honma Y; Iwasa S; Takashima A; Kato K; Hamaguchi T; Shimada Y
Br J Cancer; 2014 May; 110(11):2716-27. PubMed ID: 24800946
[TBL] [Abstract][Full Text] [Related]
7. P21 is not a prognostic marker for rectal cancer - five-year follow up study of rectal cancer in stages I-IV.
Kozłowska-Geller MA; Głuszek SZ; Lewitowicz P
Contemp Oncol (Pozn); 2020; 24(4):247-251. PubMed ID: 33531872
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
9. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of EGFR gene copy number and KRAS mutation in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Bengala C; Bettelli S; Bertolini F; Sartori G; Fontana A; Malavasi N; Depenni R; Zironi S; Del Giovane C; Luppi G; Conte PF
Br J Cancer; 2010 Sep; 103(7):1019-24. PubMed ID: 20842128
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.
Nicholson S; Richard J; Sainsbury C; Halcrow P; Kelly P; Angus B; Wright C; Henry J; Farndon JR; Harris AL
Br J Cancer; 1991 Jan; 63(1):146-50. PubMed ID: 1846551
[TBL] [Abstract][Full Text] [Related]
12. EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.
Razis E; Pentheroudakis G; Rigakos G; Bobos M; Kouvatseas G; Tzaida O; Makatsoris T; Papakostas P; Bai M; Goussia A; Samantas E; Papamichael D; Romanidou O; Efstratiou I; Tsolaki E; Psyrri A; De Roock W; Bafaloukos D; Klouvas G; Tejpar S; Kalogeras KT; Pectasides D; Fountzilas G
J Cancer Res Clin Oncol; 2014 May; 140(5):737-48. PubMed ID: 24595598
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of epidermal growth factor receptor and thymidylate synthase expression in primary liver cancer].
Guo FY; Yang J; Xiong SM; Zhu MQ; Gao S; Li JP
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):666-669. PubMed ID: 30481863
[No Abstract] [Full Text] [Related]
14. Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays.
Yang XQ; Chen C; Peng CW; Hou JX; Liu SP; Qi CB; Gong YP; Zhu XB; Pang DW; Li Y
Int J Nanomedicine; 2011; 6():2265-73. PubMed ID: 22072864
[TBL] [Abstract][Full Text] [Related]
15. [Immunohistochemical study on the expression of epidermal growth factor receptor (EGFR) in human colorectal carcinomas].
Takemura K; Obara T; Okano S; Yokota K; Ura H; Saitoh Y; Koike Y; Okamura K; Namiki M
Nihon Shokakibyo Gakkai Zasshi; 1991 May; 88(5):1177-83. PubMed ID: 1880949
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancer.
Tsutsui S; Ohno S; Murakami S; Hachitanda Y; Oda S
Breast Cancer Res Treat; 2002 Jan; 71(1):67-75. PubMed ID: 11859875
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the EGFR pathway coincide in colorectal cancer and impact on prognosis.
Neumann J; Wehweck L; Maatz S; Engel J; Kirchner T; Jung A
Virchows Arch; 2013 Oct; 463(4):509-23. PubMed ID: 23934607
[TBL] [Abstract][Full Text] [Related]
18. Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.
D'Angelo SP; Janjigian YY; Ahye N; Riely GJ; Chaft JE; Sima CS; Shen R; Zheng J; Dycoco J; Kris MG; Zakowski MF; Ladanyi M; Rusch V; Azzoli CG
J Thorac Oncol; 2012 Dec; 7(12):1815-1822. PubMed ID: 23154553
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of epidermal growth factor receptor, vascular endothelial growth factor and hypoxia-inducible factor-1 with special reference to local responsiveness to neoadjuvant chemoradiotherapy and disease recurrence after rectal cancer surgery.
Toiyama Y; Inoue Y; Saigusa S; Okugawa Y; Yokoe T; Tanaka K; Miki C; Kusunoki M
Clin Oncol (R Coll Radiol); 2010 May; 22(4):272-80. PubMed ID: 20117921
[TBL] [Abstract][Full Text] [Related]
20. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
